ResMed, Inc.

RMD

US7611521078

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 11:30:27 20/09/2024 pm IST			5-day change	1st Jan Change
245.40 ^USD	+0.99%		-1.38%	+42.72%

18/09	Equity Markets Fall After 50-Basis-Point Fed Rate Cut	MT
18/09	Equity Markets Fall After 50-Basis-Point Fed Rate Cut	MT

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Vous êtes déja client ? Log In

Latest news about ResMed, Inc.

Equity Markets Fall After 50-Basis-Point Fed Rate Cut	19/09	MT
Equity Markets Fall After 50-Basis-Point Fed Rate Cut	19/09	MT
Sector Update: Health Care Stocks Fall	19/09	MT
US Equities Markets End Lower Wednesday After FOMC Cuts Rates	19/09	MT
Equity Markets Eke Out Gains Ahead of Fed Decision	18/09	MT
Sector Update: Health Care Stocks Advance in Afternoon Trading	18/09	MT
US Equity Indexes Rise in Choppy Trading Ahead of Fed's Policy Move, Guidance on Easing Path	18/09	MT
US Equity Indexes Decline as Investors Await Fed's Policy Move, Guidance on Easing Path	18/09	MT
Wolfe Research Downgrades ResMed to Underperform From Peer Perform, Price Target is $180	18/09	MT
Analyst recommendations: Blackstone, Resmed, Reddit, On Holding, Hiscox...	18/09
Resmed Insider Sold Shares Worth $1,262,800, According to a Recent SEC Filing	14/09	MT
ResMed Insider Sold Shares Worth $3,646,950, According to a Recent SEC Filing	11/09	MT
Resmed Insider Sold Shares Worth $479,800, According to a Recent SEC Filing	07/09	MT
ResMed Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 10:00 AM	04/09
Needham Downgrades ResMed to Hold From Buy	04/09	MT
ResMed Elects Christopher DelOrefice to the Board	16/08	CI
Resmed Insider Sold Shares Worth $2,166,000, According to a Recent SEC Filing	14/08	MT
Resmed Insider Sold Shares Worth $3,145,905, According to a Recent SEC Filing	09/08	MT
Resmed Insider Sold Shares Worth $10,419,552, According to a Recent SEC Filing	07/08	MT
UBS Adjusts Price Target on ResMed to $225 From $210, Maintains Neutral Rating	05/08	MT
Recession Fears Drag Australian Shares to More than Two-Month Low	05/08	MT
ResMed Shares Hit 52-Week High After Reporting Strong Results on Friday	05/08	MT
RBC Adjusts ResMed's Price Target to $206 From $204, Keeps Sector Perform Rating	02/08	MT
Mizuho Securities Adjusts ResMed Price Target to $230 From $220	02/08	MT
KeyBanc Adjusts Price Target on ResMed to $251 From $238	02/08	MT

ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (50.4%); - masks (37.9%); - software as a service (11.7%). At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia. The United States accounts for 61.4% of net sales.

Employees

9,980

Sector

Advanced Medical Equipment & Technology

Calendar

30/09/2024 - Investor Day

More about the company